Franck E. Nicolini

7.7k citations
56 papers · 3.0k · 2 hit papers · h-index 19

Impact in

  • Hematology top 0.2%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
  • Genetics top 0.2%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Chronic Myeloid Leukemia Treatments 53
    • Acute Myeloid Leukemia Research 4
    • Chronic Lymphocytic Leukemia Research 39
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 6

Franck E. Nicolini

56 papers receiving 2.9k citations

Franck E. Nicolini's Hit Papers

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia 2016 · 321 citations
3210+5+10Years since publication2505007501000

Peers

Franck E. Nicolini
Comparison fields: 5 of 65
  • Hematology 2.7k
  • Genetics 1.8k
  • Rheumatology 1.1k
  • Oncology 425
  • Pathology and Forensic Medicine 217
Replace Concepción Boqué with:
Concepción Boqué Spain
M. Brigid Bradley‐Garelik United States
Laurence Legros France
Philipp D. le Coutre Germany
Fausto Castagnetti Italy
Beatriz Moiraghi Argentina
Ron Paquette United States
Athena Countouriotis United States
Franck E. Nicolini France
Marilina Amabile Italy
Franck E. Nicolini relative to Concepción Boqué Spain Concepción Boqué's profile →
Citations per field
00.5×1.5×2.5×
Concepción Boqué · 1×
Citations per year

Countries citing papers authored by Franck E. Nicolini

Since Specialization
Citations

This map shows the geographic impact of Franck E. Nicolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck E. Nicolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck E. Nicolini more than expected).

Fields of papers citing papers by Franck E. Nicolini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck E. Nicolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck E. Nicolini. The network helps show where Franck E. Nicolini may publish in the future.

Co-authors

The 25 scholars most cited alongside Franck E. Nicolini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Franck E. Nicolini Line = papers co-authored together Franck E. Nicolini links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
Hit paper breakdown →
20101057
2 2011373
3
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia
Hit paper breakdown →
2016321
4 2011321
5 2013172
6 201775
7 201050
8 201848
9 201046
10 201133
11 201231
12 201128
13 201027
14 200925
15 201425
16 200924
17 201324
18 201422
19 201321
20 201217

About Franck E. Nicolini

Franck E. Nicolini is a scholar working on Hematology, Genetics, Rheumatology, Public Health, Environmental and Occupational Health and Organic Chemistry, having authored 56 papers that have together received 3.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (53 papers), Chronic Lymphocytic Leukemia Research (39 papers), Eosinophilic Disorders and Syndromes (24 papers), Acute Lymphoblastic Leukemia research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (4 papers), Click Chemistry and Applications (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Hematology (2.7k citations), Genetics (1.8k citations), Rheumatology (1.1k citations), Oncology (425 citations) and Pathology and Forensic Medicine (217 citations). Franck E. Nicolini has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Delphine Réa, François‐Xavier Mahon, Laurence Legros, François Guilhot, Gabriel Étienne, Joëlle Guilhot, Bruno Varet, Aude Charbonnier, Philippe Rousselot and Agnès Guerci. Their work appears in journals such as Blood, Leukemia Research, Cancer, Journal of Clinical Oncology and Cancer Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact